Partnerships, New Treatment, and a Thomson Reuters Citation Laureate

Posted on by

While browsing the news, these are some of the stories that rose to the top!

  • Cornell University in partnership with Memorial Sloan Kettering is opening a new $10 million Center of Cancer Nanotechnology Excellence, bringing together scientists, engineers, biologists, and physicians to develop and translate new cancer care applications based on nanotechnology.
  • Collaborative enterprise announced between Memorial Sloan Kettering and Illumina, Inc. to conduct research studies critical to understanding the biology of circulating tumor DNA (ctDNA). The studies aim to inform the development of new strategies to diagnose and monitor cancer and to help establish ctDNA as an important marker in the study and eventual treatment of cancer. Dr. Jose Baselga, Physician-in-Chief and Chief Medical Officer, Memorial Hospital is quoted.

Continue reading →

The Latest in 3D Printing, Nano Particles, and Cancer Disparities

Posted on by

Some of the stories that caught my attention:

  • A cancer patient in Spain has received a 3D-printed chest prosthetic made of lightweight titanium in a first-of-its-kind surgery. Surgeons at Salamanca University Hospital in Salamanca Spain worked with an Australian-based medical company to build the titanium 3D sternum and ribcage.
  • A study from investigators at the Massachusetts General Hospital (MGH) Cancer Center has, for the first time, identified genomic differences between the breast tumors of African American and white women, differences that could contribute to the recognized differences in recurrence rate and survival. More on their findings are discussed in the Journal of Clinical Oncology.
  • While cancer is the second leading cause of death overall in the United States, it remains the leading cause of death among U.S. Hispanics/Latinos. The finding comes from “Cancer Statistics for Hispanics/Latinos,” a comprehensive report produced every three years by the American Cancer Society and published in CA: A Cancer Journal for Clinicians.
  • In pre –clinical studies in mice, researchers with the American Chemical Society have found that injecting gold nanoparticles to mammary tissue enhances imaging. They describe their study and results in ACS Nano.